GREY:ATBPF - Post by User
Comment by
Layth1990on Feb 11, 2021 7:29pm
122 Views
Post# 32548084
RE:phase 2 study from last June
RE:phase 2 study from last JuneBecause minimum effective dose was not established. The trial showed even at the lower dose was more effective than most nsaids. This is something really good but some investors got pissed. during phase 3, there will be a dosing trial to get the lowest effective dosage ( that is what i understood)